Microbial dysbiosis and colon carcinogenesis: Could colon cancer be considered a bacteria-related disease?

Therapeutic Advances in Gastroenterology

Volumn 6, Issue 3, 2013, Pages 215-229

  Sobhani, Iradj ^a   Amiot, Aurelien ^b   Baleur, Yann ^b   Levy, Michael ^b   Auriault, Marie Luce ^a   Van Nhieu, Jeanne Tran ^a   Delchier, Jean Charles ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

bacteria; bacteria host interaction; colon cancer; environment; genetic

Indexed keywords

EID: 84993820006     PISSN: 1756283X     EISSN: 17562648     Source Type: Journal    
DOI: 10.1177/1756283X12473674     Document Type: Review

References (68)

1. Aparicio T. Kermorgant S. Darmoul D. Guilmeau S. Hormi K. Mahieu-Caputo D. et al. (2005) Leptin and Ob-Rb receptor isoform in the human digestive tract during fetal development. J Clin Endocrinol Metab 90: 6177–6184.
2. Arthur J. Jobin C. (2011) The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis 17: 396–409.
3. Arthur J. Perez-Chanona E. Muhlbauer M. Tomkovich S. Uronis J. Fan T. et al. (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338: 120–123.
4. Arumugam M. Raes J. Pelletier E. Le P. Yamada T. Mende D. et al. (2011) Enterotypes of the human gut microbiome. Nature 473: 174–180.
5. Bach J. (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347: 911–920.
6. Baker K. Zhang Y. Jin C. Jass J. (2004) Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum? J Clin Pathol 57: 1089–1093.
7. Baker M. (2009) Stem cells: fast and furious. Nature 458: 962–965.
8. Balkwill F. Mantovani A. (2010) Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther 87: 401–406.
9. Bolstad A. Jensen H. Bakken V. (1996) Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum. Clin Microbiol Rev 9: 55–71.
10. Bordonaro M. Lazarova D. Sartorelli A. (2008) Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk? Cell Cycle 7: 1178–1183.
11. Bretthauer M. Kalager M. (2012) Colonoscopy as a triage screening test. N Engl J Med 366: 759–760.
12. Calle E. (2007) Obesity and cancer. BMJ 335: 1107–1108.
13. Castellarin M. Warren R. Freeman J. Dreolini L. Krzywinski M. Strauss J. et al. (2012) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22: 299–306.
14. Clevers H. (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469–480.
15. Coic Y. Baleux F. Poyraz O. Thibeaux R. Labruyere E. Chretien F. et al. (2012) Design of a specific colonic mucus marker using a human commensal bacterium cell surface domain. J Biol Chem 287: 15916–15922.
16. Cuevas-Ramos G. Petit C. Marcq I. Boury M. Oswald E. Nougayrede J. (2010) Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A 107: 11537–11542.
17. de Fillipo C. Cavalieri D. Di P. Ramazzotti M. Poullet J. Massart S. et al. (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107: 14691–14696.
18. deMartel C. Ferlay J. Franceschi S. Vignat J. Bray F. Forman D. et al. (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13: 607–615.
19. Deschner E. (1974) Experimentally induced cancer of the colon. Cancer 34(Suppl. S3): 824–828.
20. Eckburg P. Bik E. Bernstein C. Purdom E. Dethlefsen L. Sargent M. et al. (2005) Diversity of the human intestinal microbial flora. Science 308: 1635–1638.
21. Fearon E. Vogelstein B. (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759–767.
22. Frezza E. Wachtel M. Chiriva-Internati M. (2006) Influence of obesity on the risk of developing colon cancer. Gut 55: 285–291.
23. Gaboriau-Routhiau V. Lecuyer E. Cerf-Bensussan N. (2011) Role of microbiota in postnatal maturation of intestinal T-cell responses. Curr Opin Gastroenterol 27: 502–508.
24. Goldstein N. (2006) Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification. Am J Clin Pathol 125: 146–153.
25. Greer J. O'Keefe S. (2011) Microbial induction of immunity, inflammation, and cancer. Front Physiol 1: 168.
26. Hemminki K. Chen B. (2004) Familial risk for colorectal cancers are mainly due to heritable causes. Cancer Epidemiol Biomarkers Prev 13: 1253–1256.
27. Hirose Y. Hata K. Kuno T. Yoshida K. Sakata K. Yamada Y. et al. (2004) Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice. Carcinogenesis 25: 821–825.
28. Kinzler K. Vogelstein B. (1996) Lessons from hereditary colorectal cancer. Cell 87: 159–170.
29. Kostic A. Gevers D. Pedamallu C. Michaud M. Duke F. Earl A. et al. (2012) Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 22: 292–298.
30. Ley R. (2010) Obesity and the human microbiome. Curr Opin Gastroenterol 26: 5–11.
31. Lichtenstein P. Holm N. Verkasalo P. Iliadou A. Kaprio J. Koskenvuo M. et al. (2000) Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78–85.
32. Lindhurst M. Sapp J. Teer J. Johnston J. Finn E. Peters K. et al. (2011) A mosaic activating mutation in AKT 1 associated with the Proteus syndrome. N Engl J Med 365: 611–619.
33. Lipkin M. (1988) Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res 48: 235–245.
34. Marchesi J. Dutilh B. Hall N. Peters W. Roelofs R. Boleij A. et al. (2011) Towards the human colorectal cancer microbiome. PloS ONE 6: e20447.
35. McCoy W. Mason J. III (1951) Enterococcal endocarditis associated with carcinoma of the sigmoid; report of a case. J Med Assoc State Ala 21: 162–166.
36. McIllmurray M. Langman M. (1975) Large bowel cancer: causation and management. Gut 16: 815–820.
37. Mills S. Mathers J. Chapman P. Burn J. Gunn A. (2001) Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis. Gut 48: 41–46.
38. Noffsinger A. (2009) Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol 4: 343–364.
39. O'Keefe S. (2008) Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol 24: 51–58.
40. Pagnini C. Corleto V. Mangoni M. Pilozzi E. Torre M. Marchese R. et al. (2011) Alteration of local microflora and alpha-defensins hyper-production in colonic adenoma mucosa. J Clin Gastroenterol 45: 602–610.
41. Pédron T. Mulet C. Dauga C. Frangeul L. Chervaux C. Grompone G. et al. (2012) A crypt-specific core microbiota resides in the mouse colon. MBio 3: e00116–e00112.
42. de Ponz L. Roncucci L. Di D. Tassi L. Smerieri O. Amorico M. et al. (1988) Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel. Cancer Res 48: 4121–4126.
43. Qin J. Li R. Raes J. Arumugam M. Burgdorf K. Manichanh C. et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59–65.
44. Quintero E. Castells A. Bujanda L. Cubiella J. Salas D. Lanas A. et al. (2012) Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 366: 697–706.
45. Reikvam D. Erofeev A. Sandvik A. Grcic V. Jahnsen F. Gaustad P. et al. (2011) Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PloS ONE 6: e17996.
46. Reya T. Clevers H. (2005) Wnt signalling in stem cells and cancer. Nature 434: 843–850.
47. Sainsbury A. Goodlad R. Perry S. Pollard S. Robins G. Hull M. (2008) Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass. Cancer Epidemiol Biomarkers Prev 17: 1401–1410.
48. Savage D. (1977) Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31: 107–133.
49. Scheppach W. (1994) Effects of short chain fatty acids on gut morphology and function. Gut 35: S35–S38.
50. Shen X. Rawls J. Randall T. Burcal L. Mpande C. Jenkins N. et al. (2010) Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 1: 138–147.
51. Sobhani I. Alzahouri K. Ghout I. Charles D. Durand-Zaleski I. (2011 a) Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy. Dis Colon Rectum 54: 876–886.
52. Sobhani I. Jarrousse V. Guilemeau S. Blugeon S. Auriault M. et al. (2011 c). Colon cancer patients’ fresh stools induced intestinal precancerous lesion in germ-free mice. Gut 60(Suppl. 3): A1.
53. Sobhani I. LeGouvello S. (2009) Critical role for CD8+FoxP3+ regulatory T cells in colon cancer immune response in humans. Gut 58: 743–744.
54. Sobhani I. Lehy T. Laurent-Puig P. Cadiot G. Ruszniewski P. Mignon M. (1993) Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa. Gastroenterology 105: 22–30.
55. Sobhani I. Tap J. Roudot-Thoraval F. Roperch J. Letulle S. Langella P. et al. (2011 b) Microbial dysbiosis in colorectal cancer (CRC) patients. PloS ONE 6: e16393.
56. Sobhani I. Zeitoun J. Cahnteloup E. Charachon A. Levy M. Delchier J. (2010) Obesity and cancer: yin/yan effects of nutrition. Open Obesity J 2: 38–42.
57. Tjalsma H. Boleij A. Marchesi J. Dutilh B. (2012) A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 10: 575–582.
58. Turnbaugh P. Ley R. Mahowald M. Magrini V. Mardis E. Gordon J. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027–1031.
59. van de Wetering M. Sancho E. Verweij C. de Lau W. Oving I. Hurlstone A. et al. (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241–250.
60. Vijay-Kumar M. Aitken J. Carvalho F. Cullender T. Mwangi S. Srinivasan S. et al. (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328: 228–231.
61. Vogelmann R. Amieva M. (2007) The role of bacterial pathogens in cancer. Curr Opin Microbiol 10: 76–81.
62. Wang D. DuBois R. (2010) Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer. Gastroenterol Clin North Am 39: 697–707.
63. Whiteley L. Klurfeld D. (2000) Are dietary fiber-induced alterations in colonic epithelial cell proliferation predictive of fiber's effect on colon cancer? Nutr Cancer 36: 131–149.
64. Wilcox D. Higgins J. Bertram T. (1992) Colonic epithelial cell proliferation in a rat model of nongenotoxin-induced colonic neoplasia. Lab Invest 67: 405–411.
65. Winawer S. Zauber A. Gerdes H. O'Brien M. Gottlieb L. Sternberg S. et al. (1996) Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 334: 82–87.
66. Wu S. Rhee K. Albesiano E. Rabizadeh S. Wu X. Yen H. et al. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15: 1016–1022.
67. Zheng Y. Kramer P. Lubet R. Steele V. Kelloff G. Pereira M. (1999) Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis 20: 255–260.
68. Zhu Y. Michelle L. Jobin C. Young H. (2011) Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett 309: 119–127.